Merit Medical [MMSI] vs AptarGroup [ATR] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Merit Medical wins in 3 metrics, AptarGroup wins in 16 metrics, with 0 ties. AptarGroup appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Merit Medical AptarGroup Better
P/E Ratio (TTM) 41.98 22.56 AptarGroup
Price-to-Book Ratio 3.29 3.18 AptarGroup
Debt-to-Equity Ratio 55.14 43.12 AptarGroup
PEG Ratio -4.27 0.93 Merit Medical
EV/EBITDA 19.09 12.05 AptarGroup
Profit Margin (TTM) 8.31% 10.84% AptarGroup
Operating Margin (TTM) 12.30% 15.17% AptarGroup
EBITDA Margin (TTM) 12.30% 15.17% AptarGroup
Return on Equity 8.60% 15.26% AptarGroup
Return on Assets (TTM) 4.19% 7.10% AptarGroup
Free Cash Flow (TTM) $182.76M $349.22M AptarGroup
Dividend Yield N/A 0.90% N/A
1-Year Return -12.58% -18.95% Merit Medical
Price-to-Sales Ratio (TTM) 3.42 2.38 AptarGroup
Enterprise Value $5.38B $9.62B AptarGroup
EV/Revenue Ratio 3.75 2.67 AptarGroup
Gross Profit Margin (TTM) 48.24% 37.99% Merit Medical
Revenue per Share (TTM) $24 $54 AptarGroup
Earnings per Share (Diluted) $1.97 $5.79 AptarGroup
Beta (Stock Volatility) 0.58 0.55 AptarGroup
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Merit Medical vs AptarGroup Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Merit Medical-4.23%-6.20%-11.04%-17.00%-13.71%-17.78%
AptarGroup0.24%-1.72%-3.90%-17.31%-6.98%-15.07%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Merit Medical-12.58%50.73%72.37%241.25%544.88%586.76%
AptarGroup-18.95%37.71%12.53%87.47%180.00%403.96%

News Based Sentiment: Merit Medical vs AptarGroup

Merit Medical

News based Sentiment: MIXED

October brought a significant leadership change alongside strong Q2 earnings and a stock price decline, creating a mixed investment narrative. While the company demonstrates positive financial momentum and technological advancements, the stock's performance and insider selling introduce uncertainty, making this a moderately important month for investors.

View Merit Medical News Sentiment Analysis

AptarGroup

News based Sentiment: MIXED

October was a month of contrasts for AptarGroup. While the company delivered strong Q2 earnings, increased its dividend, and demonstrated impressive EPS growth, a major antitrust lawsuit emerged, creating significant uncertainty. The mixed analyst sentiment and institutional investor activity further contribute to a complex investment picture.

View AptarGroup News Sentiment Analysis

Performance & Financial Health Analysis: Merit Medical vs AptarGroup

MetricMMSIATR
Market Information
Market Cap i$4.96B$8.63B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i669,400403,740
90 Day Avg. Volume i683,753422,917
Last Close$78.99$130.93
52 Week Range$78.12 - $111.45$129.81 - $178.03
% from 52W High-29.13%-26.46%
All-Time High$111.45 (Jan 27, 2025)$178.03 (Nov 11, 2024)
% from All-Time High-29.13%-26.46%
Growth Metrics
Quarterly Revenue Growth0.13%0.06%
Quarterly Earnings Growth-0.09%0.24%
Financial Health
Profit Margin (TTM) i0.08%0.11%
Operating Margin (TTM) i0.12%0.15%
Return on Equity (TTM) i0.09%0.15%
Debt to Equity (MRQ) i55.1443.12
Cash & Liquidity
Book Value per Share (MRQ)$25.13$41.04
Cash per Share (MRQ)$5.77$2.58
Operating Cash Flow (TTM) i$239.96M$616.20M
Levered Free Cash Flow (TTM) i$190.72M$291.79M
Dividends
Last 12-Month Dividend Yield iN/A0.90%
Last 12-Month Dividend iN/A$1.35

Valuation & Enterprise Metrics Analysis: Merit Medical vs AptarGroup

MetricMMSIATR
Price Ratios
P/E Ratio (TTM) i41.9822.56
Forward P/E i22.2922.03
PEG Ratio i-4.270.93
Price to Sales (TTM) i3.422.38
Price to Book (MRQ) i3.293.18
Market Capitalization
Market Capitalization i$4.96B$8.63B
Enterprise Value i$5.38B$9.62B
Enterprise Value Metrics
Enterprise to Revenue i3.752.67
Enterprise to EBITDA i19.0912.05
Risk & Other Metrics
Beta i0.580.55
Book Value per Share (MRQ) i$25.13$41.04

Financial Statements Comparison: Merit Medical vs AptarGroup

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)MMSIATR
Revenue/Sales i$355.35M$887.31M
Cost of Goods Sold i$183.33M$550.89M
Gross Profit i$172.02M$336.41M
Research & Development i$22.48MN/A
Operating Income (EBIT) i$42.06M$115.49M
EBITDA i$77.83M$186.15M
Pre-Tax Income i$37.96M$106.02M
Income Tax i$7.81M$27.35M
Net Income (Profit) i$30.15M$78.66M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)MMSIATR
Cash & Equivalents i$395.53M$125.84M
Total Current Assets i$958.64M$1.51B
Total Current Liabilities i$196.82M$1.21B
Long-Term Debt i$808.22M$612.02M
Total Shareholders Equity i$1.43B$2.55B
Retained Earnings i$725.69M$2.42B
Property, Plant & Equipment i$432.99M$66.57M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)MMSIATR
Operating Cash Flow i$57.24M$100.50M
Capital Expenditures iN/A$79,000
Free Cash Flow i$19.05M$23.41M
Debt Repayment i$0$-4.55M
Common Stock Repurchase iN/A$-80.00M

Short Interest & Institutional Ownership Analysis

MetricMMSIATR
Shares Short i3.22M1.07M
Short Ratio i5.912.48
Short % of Float i0.08%0.02%
Average Daily Volume (10 Day) i669,400403,740
Average Daily Volume (90 Day) i683,753422,917
Shares Outstanding i58.74M66.50M
Float Shares i57.79M65.34M
% Held by Insiders i0.02%0.01%
% Held by Institutions i1.08%0.96%

Dividend Analysis & Yield Comparison: Merit Medical vs AptarGroup

MetricMMSIATR
Last 12-Month Dividend iN/A$1.35
Last 12-Month Dividend Yield iN/A0.90%
3-Year Avg Annual Dividend iN/A$1.50
3-Year Avg Dividend Yield iN/A0.32%
3-Year Total Dividends iN/A$4.51
Ex-Dividend DateN/AFeb 05, 2025